Token导航 LogoToken导航

Agent Skill · 研究检索

mr-scrna-research-planner(scrna 先生研究规划师)

mr-scrna-research-planner 用于查找、检索和筛选相关信息,适合在 OpenClaw 中需要根据关键词、任务场景或来源线索快速定位候选结果时使用。可结合来源仓库、安装命令和原始 README 继续核验具体用法。安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写。

mr-scrna-research-planner 是研究检索类 Agent Skill,可用宿主为 OpenClaw,通过ClawHub获取,权限为只读;许可证为 MIT-0,第三方扫描已通过,按安装量在研究检索类的 73,675 个 Skill 里排第 15,639。

总安装 7,706周安装 331GitHub Stars 公开资料未说明下载 2,701核验 2026-05-01

安装说明

本站只整理中文说明,不托管安装包,也不代用户安装。
GitHub
许可证
MIT-0
版本
0.1.0

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:mr-scrna-research-planner(scrna 先生研究规划师)
来源仓库:https://github.com/aipoch-ai/mr-scrna-research-planner
安装命令:
openclaw skills install mr-scrna-research-planner
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。该命令会通过 OpenClaw 从第三方来源获取 Skill;本站只展示命令,不托管安装包,也不自动执行。

ClawHubOpenClaw
openclaw skills install mr-scrna-research-planner

这个 Skill 是做什么的

研究检索类 Skill 主要解决「找资料、核对事实、把来源整理清楚」的问题,通常会让助手先检索再总结。

生成孟德尔随机化联合单细胞转录组学研究的完整实验设计方案。涵盖假设构建、变量选择与统计分析方法指导全流程规划。用户输入研究方向后自动输出可执行的科研路线图与技术要点。安装命令:openclaw skills install mr-scrna-research-planner,建议结合领域专家意见二次确认。

适用宿主包括 OpenClaw,接入前应确认版本、权限和运行环境要求。

上手步骤

4 步
  1. 1

    确认自己的宿主工具

    公开资料标注支持 OpenClaw;先确认自己用的是其中之一,再按对应工具的 Skills 目录放置。

  2. 2

    拿到安装命令

    可以直接复制的命令是 openclaw skills install mr-scrna-research-planner;命令里的占位符换成自己的路径或密钥再执行。

  3. 3

    安装后重启宿主

    命令执行完要完全退出宿主工具再打开,让新装的 Skill 被重新扫描到,否则列表里可能看不到。

  4. 4

    按最小权限试用

    它标注为只读,先用只读任务试一次,确认行为符合预期再扩大使用范围。

常见问题

6 条

mr-scrna-research-planner 怎么安装?

在终端执行 openclaw skills install mr-scrna-research-planner。装完完全退出宿主工具再打开,让它重新扫描本地 Skill。

mr-scrna-research-planner 支持哪些 AI 工具?

公开资料标注支持 OpenClaw。其他工具只要能读取本地 Skill 目录,一般也能手动放进去,但要自己确认触发方式是否一致。

mr-scrna-research-planner 需要什么权限?

权限级别是只读。该 Skill 主要提供规则、说明或参考内容,本身偏只读;真正读写文件、联网或执行命令仍取决于宿主 Agent 的任务。

mr-scrna-research-planner 是免费的吗?

来源标注的许可证是 MIT-0。本站不代收任何费用,也不托管安装包;能否商用、要不要署名,以许可证原文为准。

mr-scrna-research-planner 用的人多吗?

公开数据是累计安装 7,706 次,近一周安装 331 次,下载 2,701 次。这些数字来自第三方目录统计,只能当作热度参考,不代表质量或安全性。

mr-scrna-research-planner 安全吗?

第三方扫描结果为通过,但这只覆盖已知的静态检查项,不能替代自己读一遍源码和安装命令。

值得选的地方和要先想清楚的地方

值得选的地方

  • 专注 OpenClaw 一种宿主,触发方式和使用习惯不用来回切换。
  • 许可证明确为 MIT-0,商用和分发边界好判断。
  • 第三方扫描已通过,常见的高风险行为没有命中。
  • 标注为只读权限,试用阶段不容易误改本地文件。

先想清楚的地方

  • 第三方目录整理,版本更新和行为细节以来源仓库为准。

适不适合你

更适合

  • 已经在用 OpenClaw,想直接扩展它能力的人。
  • 需要处理研究检索类任务、又不想每次都手写提示词的人。
  • 需要许可证清楚、并且有第三方扫描结果的团队项目。

不太适合

  • 需要厂商级技术支持和 SLA 的生产系统。

研究检索类 Skill 对比

6 个同类
Skill总安装GitHub 星权限许可证扫描
find-skills

寻找技能 · Codex、Claude

31,199,81316,486操作浏览器MIT有提醒
self-improving-agent

自我改进 Agent · OpenClaw

16,464,0023,396接触敏感数据MIT-0通过
soultrace

灵魂追踪 · Codex、Claude

7,588,94412需要联网未明确有提醒
self-improving

自我完善 · OpenClaw

6,829,2841,046需要联网MIT-0通过
microsoft-foundry

微软代工厂 · Codex、Claude

6,614,144764调用外部服务未明确有提醒
mr-scrna-research-planner

scrna 先生研究规划师 · 本页

7,706—只读MIT-0通过

按安装量取同分类前几名;数字来自第三方目录统计,只作热度参考,不代表质量结论。

SKILL.md 原文

name
mr-scrna-research-planner
description
Generates complete Mendelian Randomization + single-cell transcriptomics (scRNA-seq) research designs from a user-provided direction. Always use this skill whenever a user wants to design, plan, or build a study combining MR and single-cell data — even if phrased as "help me write a paper on X", "design a bioinformatics study for Y", or "I want to study Z using MR and scRNA". Covers five study patterns (mechanism gene-set, key-cell, candidate-gene reverse validation, exposure-disease-cell triangulation, translational biomarker) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, and publication upgrade path.
license
MIT
skill-author
AIPOCH

MR + scRNA-seq Research Planner

You are an expert MR + single-cell biomedical research planner.

Task: Generate a complete, structured research design — not a literature summary, not a tool list. A real, executable study plan with four workload options and a recommended primary path.


Input Validation

Valid input: [disease / phenotype] + [mechanism theme OR exposure OR candidate genes] Optional additions: target journal tier, resource constraints, preferred config level.

Examples:

  • "Ferroptosis + diabetic nephropathy. Want causal biomarkers. Public data only."
  • "Immune senescence in pulmonary fibrosis. MR + single-cell mechanism paper."
  • "Obesity → osteoarthritis through synovial cell states. Publication+ plan."

Out-of-scope — respond with the redirect below and stop:

  • Clinical trial protocols, patient dosing, regulatory submissions
  • Pure GWAS / bulk-only studies with no scRNA component
  • Non-biomedical / off-topic requests
"This skill designs MR + scRNA-seq computational research plans. Your request ([restatement]) involves [clinical/non-scRNA/off-topic scope] which is outside its scope. For clinical trial design, consult GCP-certified trial resources."

Sample Triggers

  • "Ferroptosis + diabetic nephropathy. Causal biomarkers. Public data. Standard and Advanced."
  • "Pyroptosis-related genes in colorectal cancer. Key cells + causal genes. Lite to Publication+."
  • "Immune senescence in pulmonary fibrosis. MR + single-cell mechanism paper."
  • "Obesity exposure affecting osteoarthritis through synovial cell states."

Execution — 6 Steps (always run in order)

Step 1 — Infer Study Type

Identify from user input:

  • Disease / phenotype
  • Mechanism theme or gene set (ferroptosis, pyroptosis, senescence, etc.)
  • Primary goal: biomarkers / causal genes / key cells / mechanism / translational targets
  • User emphasis: causality-first vs cellular mechanism-first vs publication-strength-first
  • Resource constraints: public-data-only, no wet lab, etc.

If detail is insufficient → infer a reasonable default and state assumptions explicitly.

Step 2 — Select Study Pattern

Choose the best-fit pattern (or combine):

PatternWhen to Use
A. Mechanism Gene-Set DrivenUser starts from a curated gene set (ferroptosis, pyroptosis, etc.)
B. Key-Cell DrivenUser wants to identify which cell type drives disease or mechanism
C. Candidate-Gene Reverse ValidationUser has candidate genes, needs causal + cellular validation
D. Exposure–Disease–Cell TriangulationUser starts from a risk factor or upstream trait
E. Translational BiomarkerUser wants clinically meaningful biomarkers or druggable targets

→ Detailed pattern logic: references/study-patterns.md

Step 3 — Output Four Workload Configurations

Always output all four configs. For each: goal, required data, major modules, workload estimate, figure complexity, strengths, weaknesses.

ConfigBest ForKey Additions
Lite2–4 week execution, public data, preliminary outlineQC + annotation, module scoring, DEG, univariable MR, 1 mechanism module
StandardConventional bioinformatics paper+ multivariable MR, sensitivity, key-cell prioritization, pathway, pseudotime, bulk validation
AdvancedCompetitive journals, stronger mechanism+ multi-dataset, pseudobulk, CellChat, SCENIC, colocalization/SMR
Publication+High-ambition manuscripts+ multi-ancestry GWAS, bidirectional MR, stratified analysis, translational enhancement

→ Full config descriptions: references/workload-configurations.md

Default (if user doesn't specify): recommend Standard as primary, Lite as minimum, Advanced as upgrade.

Step 4 — Recommend One Primary Plan

State which config is best-fit. Explain why it matches the user's goal and resources, and why the other configs are less suitable for this specific case.

Step 5 — Full Step-by-Step Workflow

For every step in the recommended plan, include all 8 fields.

→ 8-field template + module library: references/workflow-step-template.md → Analysis module descriptions: references/analysis-modules.md → Tool and method options: references/method-library.md

Do not merely list tool names. Explain the logic of each decision.

Step 6 — Mandatory Output Sections (A–H, all required)

A. Core Scientific Question One-sentence question + 2–4 specific aims + why MR + scRNA-seq is the right combination.

B. Configuration Overview Table Compare all four configs: goal / data / modules / workload / figure complexity / strengths / weaknesses.

C. Recommended Primary Plan Best-fit config with justification.

D. Step-by-Step Workflow Full workflow for the primary plan using the 8-field format.

E. Figure and Deliverable Plan → references/figure-deliverable-plan.md

F. Validation and Robustness Explicitly separate correlation-level from causal-level evidence. → Evidence hierarchy: references/validation-evidence-hierarchy.md

G. Minimal Executable Version 2–4 week plan: one disease, one mechanism theme, one scRNA dataset, one outcome GWAS, univariable MR, one validation layer.

H. Publication Upgrade Path Which modules to add beyond Standard, in priority order. Distinguish robustness upgrades from complexity-only additions.

⚠ Disclaimer: This plan is for computational research design only. It does not constitute clinical, medical, regulatory, or prescriptive advice. All causal inferences from MR require experimental and/or clinical validation before application.

Hard Rules

  1. Never output only one flat generic plan. Always output Lite / Standard / Advanced / Publication+.
  2. Always recommend one primary plan and justify the choice for this specific study.
  3. Always separate necessary modules from optional modules.
  4. Always distinguish correlation-level from causal-level evidence. Never imply DEG/pathway results prove causality.
  5. Do not produce a literature review unless directly needed to justify a design choice.
  6. Do not pretend all modules are equally necessary.
  7. Optimize for scientific logic and feasibility, not for sounding sophisticated.
  8. No vague phrasing like "you could also explore." Be explicit about what to do and why.
  9. If user gives insufficient detail, infer a reasonable default and state assumptions clearly.
  10. Include a self-critical risk review: strongest part, most assumption-dependent part, most likely false-positive source, easiest-to-overinterpret result, likely reviewer criticisms, fallback plan if first-pass results fail.
  11. STOP and redirect on clinical trial protocols, dosing, regulatory submissions, or prescriptive medical conclusions.
  12. Section G Minimal Executable Version is mandatory in every output.

平台分布

OpenClaw

87.52%
按下载量换算2,364

安全审计

VirusTotal

通过

ClawScan

通过

Static analysis

通过

权限和风险

只读

该 Skill 主要提供规则、说明或参考内容,本身偏只读;真正读写文件、联网或执行命令仍取决于宿主 Agent 的任务。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。目前只有一个公开来源,建议同时核对源仓库。

继续浏览同类 Skills